You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Details for New Drug Application (NDA): 021341


✉ Email this page to a colleague

« Back to Dashboard


NDA 021341 describes BEXTRA, which is a drug marketed by Gd Searle and is included in one NDA. Additional details are available on the BEXTRA profile page.

The generic ingredient in BEXTRA is valdecoxib. Additional details are available on the valdecoxib profile page.
Summary for 021341
Tradename:BEXTRA
Applicant:Gd Searle
Ingredient:valdecoxib
Patents:0

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG
Approval Date:Nov 16, 2001TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength20MG
Approval Date:Nov 16, 2001TE:RLD:No

Expired US Patents for NDA 021341

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ⤷  Sign Up ⤷  Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ⤷  Sign Up ⤷  Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ⤷  Sign Up ⤷  Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.